Company intelligence / Profile preview

Taylor Pharmaceuticals

Ownership: Private
Employees: ~30
Development stage: Other

Overview

Taylor Pharmaceuticals specialized in contract manufacturing and development of sterile solutions for otic, ophthalmic, and parenteral use as well as ointments. They expanded into lyophilization to address global shortages in freeze-drying capacity. Their client base included between 45–50 pharmaceutical and biotech companies at any given time.

Modalities: Sterile solutionsSmall molecule formulationsOintmentsParenteralsLyophilized products
Industry: Contract Manufacturing Organization

Partnerships

Pharma/Biotech client base

Beyond the preview

Go deeper on Taylor Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Taylor Pharmaceuticals.

Explore the full profile